Sale of OJSC " Pharmstandard ", one of the largest manufacturers of medicinal products in the Russian Federation, for the first nine months of 2014 fell by 13% to 24, 76 billion compared with the same period last year, which is explained by the selection of OTC division into a separate company " Noticefrom ", informs the Company.
However, Sales of " Pharmstandard " except for the 27 items included in " Noticefrom ", showed an increase of 16% in the reporting period, reported in the report.
in the 3rd quarter revenues of " Pharmstandard " was 7, 537 billion rubles, which is 39% lower than the year before. The main reason for the fall - allocation of the OTC segment in a separate structure.
" Pharmstandard " belong to eight plants for the manufacture of medicinal products, located in Kursk, Ufa, Tomsk, Vladimir and Kharkiv (Ukraine), as well as the enterprise for the production of medical equipment in Tyumen. The controlling shareholder of " Pharmstandard " with a share of 54, 32% is Firm Augment Investments Limited, which is owned by Victor Haritonin and Yegor Kulkov, 18, 74% owned by the organization Bristley, whose owner is a member of the Board of Directors of Russian pharmaceutical manufacturer Alexander Schuster.
sections: Politics |